GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds
-
June 23, 2025
- HealthDayTV HealthDay Reporter
In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.
Health News is provided as a service to Professional Village Pharmacy site users by HealthDay. Professional Village Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.
